Cattle infected with Neospora caninum readily experience transplacental parasite transmission, presumably after maternal parasitemia, leading to abortion or birth of congenitally infected calves. Cytotoxic T lymphocytes (CTL) are important mediators of protective immunity against Toxoplasma gondii, an intracellular apicomplexan protozoan closely related to N. caninum. In this study, N. caninum-specific CTL expanded from peripheral blood mononuclear cells of two major histocompatibility complex-mismatched, experimentally infected cattle were identified by using a 51 Cr release cytotoxicity assay. Enrichment and blocking of CD4 ؉ -and CD8 ؉ -T-lymphocyte effector subsets indicated that CD4 ؉ CTL killed N. caninum-infected, autologous target cells and that killing was mediated through a perforin/granzyme pathway. Detection and characterization of CTL responses to N. caninum in the natural, outbred, bovine host will facilitate identification of immunogens and design of immunization strategies to induce parasite-specific CTL against transplacental N. caninum transmission in cattle.
Neosporosis, caused by the apicomplexan protozoan parasite Neospora caninum, is a major cause of infectious abortion and congenital disease in cattle worldwide (16) . Unlike other infectious causes of abortion in cattle, vaccines proven effective at limiting outbreaks or preventing future abortions are not available; thus, vaccine development to prevent N. caninuminduced abortion is a high research priority. The protective immune responses and antigens to be targeted for vaccine development against neosporosis in cattle are unknown.
Some degree of protective immunity to N. caninum transplacental transmission, a major mode of natural transmission (14, 41) , develops in both experimentally and naturally infected cattle. Cattle experimentally infected with N. caninum before pregnancy and challenged with tachyzoites during mid-gestation developed sufficient immunity to protect against vertical transmission (21) . In natural herd outbreaks, epidemiologic evidence that supports the development of protective immunity includes the following. (i) Cows with chronic N. caninum infection, as indicated by avidity enzyme-linked immunosorbent assay (ELISA), were less likely to abort N. caninum infected fetuses than cows with acute infection (31) . (ii) Epidemic N. caninum-associated abortions did not occur in chronically infected dams (40) . (iii) Finally, only 5 to 10% of infected cattle that aborted an infected fetus subsequently aborted a second N. caninum-infected fetus (1, 32) . Because some immune protection develops in natural and experimental infections, priming protective immune responses and stimulating memory responses via targeted immunization during critical periods before or during gestation are realistic strategies for limiting congenital neosporosis.
CD8
ϩ T lymphocytes that function as cytotoxic-T-lymphocytes (CTL) are important in immune control of murine and human infections with Toxoplasma gondii, an intracellular protozoan closely related to N. caninum. This has been demonstrated by adoptive transfer (7, 35) and depletion of CD8 ϩ -Tlymphocyte populations (18, 34) . CTL are present in cattle infected with other intracellular pathogens, including viral (8) , bacterial (27) , and protozoal (9) agents. CTL are considered major antiparasite effectors in bovine theileriosis, for which the generation of CTL is closely related to control, and macroschizont-infected cells are killed in a major histocompatibility complex (MHC) class I-restricted manner (20) . CTL are therefore expected to contribute to immune control of bovine N. caninum infections.
Our overall hypothesis is that induction of N. caninum-specific CTL through immunization will limit transplacental N. caninum transmission in cattle. The purpose of the present study is to demonstrate N. caninum-specific CTL in the peripheral blood of cattle experimentally infected with the parasite and to determine the cell type mediating CTL activity. We describe here a 51 Cr release cytotoxicity assay for identifying N. caninum specific CTL in cattle and provide evidence that killing is mediated by CD4 ϩ CTL through a perforin/granzyme secretory pathway. These data lay the foundation for future studies to determine whether N. caninum-specific CTL induced prior to and during gestation will limit transplacental parasite transmission in the outbred, bovine host.
American Holstein cattle have been confirmed by exon 2 cloning and sequencing (J. Y. Park, J. Norimine, and C. J. Davies, unpublished results). Three of the class II haplotypes carried by these cattle (DH8A, DH16A, and DH22C) have duplicated DQA and DQB genes; the fourth haplotype (DH24A) has only one DQA and one DQB gene (3, 12) . The BoLA-DQ haplotypes of the cows were inferred from BoLA-A and DRB3 typing on the basis of haplotypes defined in the Fifth and Seventh International BoLA Workshops (11, 12, 26, 38) (BoLA nomenclature website [http://www.projects.roslin.ac.uk/bolahome.html]).
Cattle were infected with an initial dose of 10 7 N. caninum Nc-1 strain tachyzoites split between intravenous and intramuscular routes. They were reinfected intramuscularly at monthly intervals with 5 ϫ 10 6 Nc-1 tachyzoites and monitored periodically for persistent N. caninum infection by using a competitive inhibition ELISA specific for N. caninum (5) available through the Washington Animal Disease Diagnostic Laboratory, Pullman.
Parasites. The Nc-1 strain of N. caninum tachyzoites were maintained by regular serial passage in Vero cells in RPMI 1640 supplemented with 2% fetal bovine serum (HyClone, Logan, Uah), 2 mM glutamine, 10 mM HEPES buffer, and 10 g of gentamicin/ml. Tachyzoites were isolated from the cells between passages 5 and 25 (6) . Vero cell debris was removed by centrifugation at 500 ϫ g for 5 min, and then the supernatant containing tachyzoites was filtered through a 10-m (pore-size) Magna nylon filter (Osmonics, Inc., Kent, Wash.) to remove additional Vero cell debris. Tachyzoites were washed twice in Hanks balanced salt solution, counted with a hemocytometer by using trypan blue exclusion, and used for infection of experimental cattle and for infection of stimulator and target cells in 51 Cr release cytotoxicity assays. 51 Cr release cytotoxicity assay. 51 Cr release cytotoxicity assays were performed to detect the cytotoxic activity of stimulated lymphocytes from peripheral blood mononuclear cells (PBMC) of N. caninum-infected cattle. PBMC were collected by jugular venipuncture into 1/3 volume acid citrate dextrose and separated over Lymphoprep 1.077 (Axis-Shield PoCAS, Oslo, Norway) according to standard procedures.
(i) Target cells. Peripheral blood adherent cells (PBAC) were isolated from PBMC by adherence to polystyrene T-75 culture flasks. The PBAC were lifted with 0.5 mM EDTA in cold Hanks balanced salt solution by gentle tapping and scraping with a rubber cell scraper and then were counted on a hemocytometer with trypan blue exclusion and dispensed at 3 ϫ 10 4 targets/well into 96-well plates in RPMI 1640 supplemented with 10% fetal bovine serum (HyClone), 2 mM glutamine, 10 mM HEPES buffer, and 10 g of gentamicin/ml with 5 ϫ 10 Ϫ5 M 2-mercaptoethanol (complete RPMI). Target cells were infected with N. caninum tachyzoites at a multiplicity of infection (MOI) of 3:1 in 100 l of complete RPMI for 18 h. Immunohistochemical staining of tachyzoite-infected target cells with hyperimmune anti-N. caninum goat serum (VMRD, Inc., Pullman, Wash.) showed that more than 40% of the target cells were infected at this MOI in preliminary experiments (data not shown). Target cells were labeled with 1.25 Ci of 51 Cr (Amersham Pharmacia Biotech, Inc., Piscataway, N.J.)/well in 50 l of complete RPMI for 18 h at 37°C in 5% CO 2 and 5% humidity and then washed four times with 200 l of complete RPMI prior to the killing assay. Initially, primary cultures of autologous dermal fibroblasts established from dermal punch biopsies were used as target cells; however, demonstration of parasite-specific CTL that killed in a manner consistent with MHC restriction by using dermal fibroblasts as targets was unsuccessful.
(ii) Stimulator cells. Approximately 10 7 PBAC per T-75 flask were infected with N. caninum tachyzoites at an MOI of 2:1 and, after 18 h, irradiated at 3,000 rads by using a fixed cobalt beam for use as antigen-presenting stimulator cells.
(iii) Effector cells. For expansion of parasite-specific effector cells from the PBMC of infected cattle, approximately 10 8 ␥␦-depleted T lymphocytes were cultured with 10 7 PBAC stimulator cells in T-75 polystyrene culture flasks for 5 to 7 days in complete RPMI 1640 at 37°C in 5% CO 2 and 5% humidity. After the first round of stimulation, the lymphocytes were pelleted, resuspended in complete RPMI with 2 ng of recombinant human interleukin-2 (rhIL-2; R&D Systems, Minneapolis, Minn.)/ml, and expanded for 5 to 7 days. An additional 2 ng of rhIL-2/ml was added to the effector cultures on day 3 of stimulation with rhIL-2.
␥␦ T lymphocytes were depleted from PBMC prior to stimulation by using complement-mediated lysis. Freshly isolated PBMC were incubated with a murine monoclonal antibody against the bovine ␦ chain (GB21A) at 1 g/10 6 target cells for 60 min in Hanks balanced salt solution at 4°C with tilting and rotation and then washed once in Hanks balanced salt solution. The antibody-labeled PBMC were incubated with rabbit complement (Pel-Freez Clinical Systems, LLC, Brown Deer, Wis.) at a 1:16 dilution in complete RPMI for 30 min at 37°C and then pelleted, incubated with fresh complement at a 1:16 dilution for an additional 30 min, separated over Lymphoprep 1.077 (Axis-Shield PoCAS, Oslo, Norway), and washed twice with complete RPMI. PBMC phenotypes were evaluated by flow cytometry. ␥␦ T lymphocytes commonly comprised 20% of the initial lymphocytes from peripheral blood and were depleted to less than 4% of total lymphocytes by using complement-mediated lysis.
(iv) 51 Cr release assay. Test groups consisted of (i) effectors plus N. caninum infected, autologous, PBAC targets to demonstrate parasite-specific killing consistent with MHC-restriction; (ii) effectors plus uninfected, autologous, PBAC targets as a control for non-parasite-specific killing consistent with MHC restriction; (iii) effectors plus heterologous, infected targets as a control for parasitespecific, non-MHC-restricted killing; and (iv) effectors plus uninfected, heterologous targets to control for non-parasite-specific, non-MHC-restricted killing. Test groups were plated in replicates of three to five at various effector/target cell ratios. After the addition of effector cells, the plates were centrifuged at 500 ϫ g for 30 s and then incubated at 37°C in 5% CO 2 and 5% humidity for 4 to 6 h. At the end of incubation, 25 l of supernatant was harvested and combined with 150 l of OptiPhase HiSafe 3 scintillation fluid (Fisher Chemicals, Loughborough Leics, United Kingdom). The counts per minute (cpm) were determined in a MicroBeta TriLux beta emission counter (Perkin-Elmer Wallac, Inc., Gaithersburg, Md.) windowed for 51 Cr and transformed into the percent specific lysis by using the following calculation: % specific lysis ϭ [(mean cpm of the test sample Ϫ mean cpm of the spontaneous release)/(mean cpm of the maximal release Ϫ mean cpm of the spontaneous release)] ϫ 100. The percent spontaneous lysis (i.e., mean spontaneous cpm/mean maximal cpm) was Ͻ20% in every experiment. The standard error of the mean (SEM) was calculated by using a formula that takes individual variances within maximal, spontaneous, and experimental release wells into account (42) . A significant difference in the percent specific lysis between the experimental groups was defined as Ͼ2 SEM.
Immunofluorescence flow cytometry. PBMC and stimulated T lymphocytes were analyzed for cell phenotype by two-color flow cytometry. Lymphocytes (10 7 /ml) were suspended in phosphate-buffered saline (PBS)-1% gamma globulin free horse serum-0.02% sodium azide, and 50 l of the suspension was incubated with bovine monoclonal antibodies to CD4 (ILA11A), CD8 (CACT 80C or 7C2B), ␥␦ (GB21A), CD3 (MM1A), and CD2 (16-1E10) at 15 g/ml for 25 min at 4°C, washed three times, and pelleted at 1,500 ϫ g for 2 min. Lymphocytes were resuspended in PBS-0.02% sodium azide and incubated with fluorescein-and phycoerythrin-conjugated murine secondary antibodies (Caltag Laboratories, Burlingame, Calif.) at a 1/100 dilution in PBS-0.02% sodium azide for 25 min at 4°C. The cells were washed twice in PBS-0.02% sodium azide, fixed in 2% formaldehyde in PBS, and stored cold for flow cytometry. The fluoresceinlabeled cells were counted and analyzed on a Becton Dickinson FACSscan with CellQuest analysis software (Becton Dickinson, Franklin Lakes, N.J.). CD8 ؉ -T-lymphocyte enrichment. CD8 ϩ T lymphocytes were enriched by positive selection with magnetic beads. ␥␦-Depleted lymphocytes that had been cultured with stimulator cells for 5 to 7 days were incubated with a monoclonal antibody to bovine CD8 (CACT 80C and/or 7C2B) at 1 g/10 6 cells for 30 min at 4°C with rotation. The cells were then washed, incubated with magnetic beads coated with antibody to murine immunoglobulin G (IgG; Dynal, Oslo, Norway), eight beads/target cell in Hanks balanced salt solution for 30 min at 4°C with rotation, and separated with a magnet. The CD8 ϩ T lymphocytes adhered to beads were placed into complete RPMI with 2 ng of rhIL-2 (R&D Systems)/ml for an additional 5-to 7-day expansion period. An additional 2 ng of rhIL-2/ml was added to the cultures on day 3 of this expansion. After expansion with rhIL-2, the cells were pipetted with moderate vigor to release the cells from the beads and then evaluated for purity the day before the 51 Cr release assay by flow cytometry. CD8
ϩ -enriched effector populations were Ͼ99% CD8 ϩ , Ͻ1% CD4 ϩ , and Ͻ1% ␥␦ T lymphocytes. ؉ -T-lymphocyte enrichment. CD4 T lymphocytes were enriched by negative selection of CD8 and ␥␦ T lymphocytes with magnetic beads. ␥␦-Depleted T lymphocytes that had been cultured with stimulator cells for 5 to 7 days were incubated with monoclonal antibodies to bovine CD8 (CACT 80C and/or 7C2B) and bovine ␥␦ T lymphocytes at 1 g/10 6 cells for 30 min at 4°C with rotation. The cells were then washed, incubated with magnetic beads coated with antibody to murine IgG (Dynal, Oslo, Norway) at eight beads/target cell in Hanks balanced salt solution for 30 min at 4°C with rotation, and separated with a magnet. The CD8 and ␥␦ T lymphocytes that adhered to beads were discarded, and the remaining lymphocytes were placed into complete RPMI with 2 ng of rhIL-2 (R&D Systems)/ml for an additional 5-to 7-day expansion period. An additional 2 ng of rhIL-2/ml was added to the cultures on day 3 of this expansion. The purity was assessed by flow cytometry, and CD4 ϩ T lymphocytes generally comprised 80 to 99% of the lymphocytes. When necessary, increased purity of CD4 ϩ -enriched effector populations was attained with additional negative selection of ␥␦ T lymphocytes and CD8 ϩ T lymphocytes by using magnetic beads and the appropriate antibodies the day before the 51 Cr release assay. In several cases, CD3 Ϫ CD2 ϩ bovine NK-like cells (19) composed ca. 10% of the lymphocyte-gated population, and these cultures were discarded.
Blocking of effector subsets with monoclonal antibodies to bovine CD4 and CD8 T lymphocytes and concanamycin A. To determine the lymphocyte type mediating CTL activity, aliquots from the expanded, ␥␦-depleted effector cultures were incubated with monoclonal antibodies to bovine CD4 (30 g of ILA11A/ml) and/or a cocktail of monoclonal antibodies to bovine CD8 (15 g of CACT80C/ml plus 15 g of 7C2B/ml) in complete RPMI-10% fetal bovine serum at 4°C for 1 to 2 h before and throughout the 51 Cr release assay. To determine whether the CD8 T lymphocyte subset (blocked with antibodies to CD4) and the CD4-T-lymphocyte subset (blocked with antibodies to CD8) mediated killing via a perforin/granzyme pathway, 10 nM concanamycin A (Sigma) was added to CD4-blocked and CD8-blocked effector groups for 1 to 2 h before and throughout the 51 Cr release assay. In another experiment with cow 495 effectors (data not shown), CD8
ϩ T lymphocytes were depleted from the bulkexpanded effector population, and the effectors were 95% CD4 ϩ T lymphocytes, Ͻ1% CD8 ϩ T lymphocytes, and Ͻ1% ␥␦ T lymphocytes. Effectors were incubated with 10 nM concanamycin A for 3 h at 4°C and then washed twice prior to use in a 4.5-h 51 Cr release cytotoxicity assay. To control for possible nonspecific drug toxicity of concanamycin A on the effector population, a simultaneous 3 H proliferation assay was performed. For the proliferation assay, the same effector groups used in the 51 Cr release assay were incubated with or without 10 nM concanamycin A, washed after a 3-h incubation at 4°C, and placed in a 3-day 3 H proliferation assay. For the proliferation assay, 3 ϫ 10 5 autologous PBMC irradiated at 3,000 rads as antigen-presenting cells and 2 ϫ 10 4 effectors per well were combined with medium alone, 10 g of sonicated N. caninum tachyzoite antigen/ml, or 5 g of the mitogen concanavalin A/ml. All antibodies for flow cytometry, magnetic bead sorting, and effector subset blocking were purchased from VMRD.
RESULTS

N. caninum-infected cattle developed parasite-specific CTL.
Two Holstein cattle, 495 and 562, with disparate MHC haplotypes were infected with N. caninum tachyzoites. At 2 weeks after the initial N. caninum inoculation, a competitive inhibition ELISA specific for N. caninum (5) was positive for both cows. Cattle were reinfected at monthly intervals, and both cattle remained seropositive for antibodies to N. caninum by competitive inhibition ELISA throughout the study.
␥␦-T-lymphocyte-depleted PBMC from the infected cattle were cultured in the presence of tachyzoite-infected, irradiated PBAC for 5 to 7 days and expanded with rhIL-2 for 5 to 7 days. Results representative of three 51 Cr release cytotoxicity assays per cow obtained with expanded, ␥␦-depleted effectors and N. caninum-infected and uninfected autologous and heterologous targets for both cows are shown in Fig. 1 . Killing of autologous, infected targets by ␥␦-T-lymphocyte-depleted effectors from both cattle was significantly higher (Ͼ2 SEM) than killing of autologous uninfected targets, heterologous infected targets, and heterologous uninfected targets. These data show dosedependent, parasite-specific killing by in vitro-stimulated Tlymphocyte effectors from two cattle with different MHC haplotypes. The effectors from both MHC-mismatched cattle failed to kill heterologous, infected, and uninfected targets, and the killing is therefore consistent with MHC restriction.
Effect of monoclonal antibodies to CD4 and CD8 T lymphocytes on cytolytic activity of effectors. Murine CD8 ϩ CTL kill target cells infected with T. gondii (34) , and human CD4 ϩ CTL kill T. gondii-infected targets (33) . Because CD4 ϩ T lymphocytes frequently comprised more than 80% of our expanded, ␥␦-depleted, bulk effector cultures, blocking experiments were performed to determine whether killing was due to CD8 ϩ -and/or CD4 ϩ -T-lymphocyte effector subsets. When monoclonal antibodies to bovine CD8 were used to block killing by the CD8 ϩ -T-lymphocyte subset, the unblocked, CD4 ϩ -T-lymphocyte effector population killed infected, autologous targets ( Fig. 2 and 4) . When CD4 ϩ -T-lymphocyte effectors were blocked with monoclonal antibodies to CD4 ϩ , the unblocked, CD8
ϩ -T-lymphocyte effector population killed infected, autol- (Fig. 2) but not all (Fig. 4) experiments. When subsets were concurrently blocked with monoclonal antibodies to both CD4 and CD8 in four replicate experiments, killing of autologous, infected targets was reduced to nearbackground levels (Ͻ10% specific lysis), suggesting that the combined antibodies effectively blocked killing by both CTL subsets ( Fig. 2 and 4) . The results of subset blocking in Fig. 4 suggested that only CD4 ϩ T lymphocytes in this expanded effector population functioned as CTL.
N. caninum-specific CD4 ؉ T lymphocytes are CTL. Blocking of effector subsets by antibodies suggested that in some cases CD8 ϩ T lymphocytes functioned as CTL and, in other instances, CD8 ϩ T lymphocytes did not contribute to killing. It was not possible to consistently expand the same relative percentages of CD4 ϩ -and CD8 ϩ -T-lymphocyte effectors from the bulk, ␥␦-depleted, stimulated effector populations, and CD8 ϩ T lymphocytes generally comprised 1 to 11% of the total mixed effector population. Because CD8 ϩ T lymphocytes were often a small percentage of the effectors and antibody blocking experiments yielded equivocal results, immunomagnetic selection of subsets was undertaken to further clarify whether both the CD4 ϩ and CD8 ϩ subsets functioned as CTL. When CD8 ϩ T lymphocytes were depleted from bulk-cultured effectors to Ͻ1% of the effector population in each of five replicate experiments per cow, the CD4 ϩ -T-lymphocyte-enriched subset killed autologous targets infected with N. caninum (Fig. 3) . The results indicated that N. caninum-specific CD4 ϩ CTL were expanded from the peripheral blood of experimentally infected cattle. For five replicate experiments with CD4 ϩ -enriched effectors, cultures consisted of 90 to 100% CD4 ϩ T lymphocytes, Ͻ1% CD8 ϩ T lymphocytes, Ͻ1% ␥␦ T lymphocytes, 90 to 100% CD3 ϩ CD2ϩ T lymphocytes, and Ͻ1% CD3 Ϫ CD2 ϩ T lymphocytes by flow cytometry. Bovine NK-like cells (CD33 Ϫ CD2 ϩ ) (19) and ␥␦ T lymphocytes were each Ͻ1% of the effector populations. When CD8 ϩ T lymphocytes were positively selected with magnetic beads from expanded effector cultures, parasite-specific killing by the CD8 ϩ -enriched subset was not demonstrated (Fig. 3) . Enriched CD8 ϩ effector populations in all replicate experiments were 99 to 100% CD8 ϩ T lymphocytes, Ͻ1% CD4 ϩ T lymphocytes, Ͻ1% ␥␦ T lymphocytes, 90 to 100% CD3 ϩ CD2 ϩ T lymphocytes, and Ͻ1% CD3 Ϫ CD2 ϩ T lymphocytes by flow cytometry. Replicate experiments were performed by using effector to target ratios of 10:1 or 20:1.
Depletion and enrichment of T-lymphocyte subsets indicated that CD4 ϩ CTL were expanded from PBMC of N. caninum-infected cattle, whereas CD8 ϩ CTL at effector/target ratios of 10:1 and 20:1 were not detected in 51 Cr release assays. Killing by N. caninum-specific, CD4
؉ CTL was reduced when the perforin/granzyme pathway was blocked in vitro. To determine a potential mechanism of cell killing, effector populations were treated with concanamycin A, a metabolic inhibitor of the perforin/granzyme pathway (22, 52) . Aliquots from the mixed effector population were incubated with or without monoclonal antibodies to CD4 or CD8 with or without concanamycin A in the following combinations: (i) no antibodies, (ii) no antibodies and concanamycin A, (iii) anti-CD4, (iv) anti-CD4 and concanamycin A, (v) anti-CD8, and (vi) anti-CD8 and concanamycin A. Figure 4 is a single representative of two replicate experiments. Effectors from cow 495 were 86% CD4 ϩ , 11% CD8 ϩ , Ͻ1% ␥␦, and Ͻ1% CD3 Ϫ CD2 ϩ T lymphocytes. In all treatment groups blocked with concanamycin A, the percent specific lysis was reduced by at least 72%. The percent specific lysis was reduced by 60% with blocking of the CD4 ϩ effector population and by 74% when both CD4 ϩ and the perforin pathway were blocked. The percent specific lysis was not reduced with blocking of the CD8 ϩ effector population but was reduced by 72% when both CD8 ϩ and the perforin ϩ , Ͻ1% CD8 ϩ , and Ͻ1% ␥␦ T lymphocytes). Effectors were incubated with 10 nM concanamycin A for 3 h and then washed twice prior to use in a 4.5-h 51 Cr release cytotoxicity assay. A simultaneous 3 H proliferation assay was performed with the same effector population to control for nonspecific drug toxicity. When the perforin/granzyme pathway was blocked with 10 nM concanamycin prior to the 51 Cr release assay, killing by the purified CD4 ϩ -T-lymphocyte effectors was reduced by 40%, a statistically significant reduction compared to control cells not treated with concanamycin A. In a simultaneous 3 H proliferation assay, the effectors exposed to media alone or concanamycin A had an equally potent proliferative response to mitogen (stimulation indices of 25 and 30, respectively), indicating that treatment with concanamycin A did not affect effector cell viability in the 51 Cr release assay. Inhibition of the perforin/granzyme pathway of either bulk-cultured CD4 ϩ -T-lymphocyte effectors blocked with anti-CD8 ϩ antibody or purified CD4 ϩ T lymphocytes with magnetic beads reduced target cell lysis. Therefore, one mechanism of in vitro killing by CD4 ϩ CTL expanded in this experimental system was via perforin-granzyme release.
DISCUSSION
We showed here that two, nonpregnant, adult, female, Holstein cattle with disparate MHC haplotypes and experimentally infected with tachyzoites of N. caninum developed parasitespecific CD4 ϩ T lymphocytes that killed autologous, infected targets, but not heterologous, infected targets. Killing mediated by the CD4 ϩ T lymphocytes was therefore consistent with parasite specificity and MHC restriction. Furthermore, blocking of the perforin/granzyme pathway significantly reduced killing mediated by CD4 ϩ CTL, suggesting that N. caninumspecific, bovine CD4 ϩ CTL could kill through the perforin/ granzyme pathway.
Studies investigating the mammalian immune response to infection with N. caninum, primarily performed in mice, indicate that both CD4 ϩ and CD8 ϩ T lymphocytes (6, 23, 36) and increased levels of IFN-␥ (28, 36) are important for immune control. In cattle infected with N. caninum, T lymphocytes proliferate and produce gamma interferon (IFN-␥) in response to stimulation with parasite antigens (30) , suggesting that a cell-mediated immune response and increased levels of IFN-␥ could also be important in resistance to infection in cattle. The finding of N. caninum-specific CTL in the peripheral blood of experimentally infected cows is consistent with the paradigm of immune control of intracellular protozoa: that infection induces a protective immune response mediated by T lymphocytes. Indeed, it is well established that IFN-␥ and CTL are important in immune control of the closely related protozoan parasite T. gondii (15) ; however, the relative importance of CTL in the cell-mediated immune response of cattle to N. caninum infection, and the role of CTL in controlling transplacental transmission requires further investigation.
In cattle chronically infected with N. caninum, data consistent with a recrudescence of parasitemia and increased maternal parasite numbers during mid-gestation include (i) IFN-␥ secretion and T-lymphocyte proliferative capacity are decreased in mid-gestation regardless of N. caninum infection status (21), (ii) N. caninum antibody titers rise in mid to late gestation irrespective of time of year or parity (43) as an indicator of increased parasite numbers, and (iii) fetal infection is associated with a marked increase in maternal N. caninum antibody (17) . Decreased immune resistance in pregnant cattle infected with N. caninum may result in greater numbers of parasites crossing the placenta and increased severity of fetal lesions, culminating in abortion. Because transplacental parasite transmission is a primary method of acquisition and parasite persistence within a herd (2, 14, 41) , decreasing vertical transmission by efficacious maternal immunization could provide control of bovine neosporosis.
Our hypothesis is that induction of N. caninum-specific CTL through targeted immunization will limit transplacental N. caninum transmission in cattle. We assume that N. caninum transplacental transmission in cattle is dependent upon maternal parasitemia, an assumption supported by data from a murine congenital transmission model in which an increased maternal parasite dose correlated with an increased rate of vertical parasite transmission (Timothy Baszler, Washington State University, unpublished data). The development of a 51 Cr release cytotoxicity assay for in vitro characterization of N. caninum-specific bovine CTL was a crucial step toward investigating the role of CTL in limiting transplacental parasite transmission and neosporosis abortion in cattle.
The cattle used in these experiments had disparate BoLA-A and DRB alleles as determined by serotyping and PCR-RFLP analysis, respectively. Furthermore, the inferred DQA and DQB alleles carried by the two experimentally infected cattle were also mismatched. The MHC typing data are consistent with the observed lack of allogeneic killing by CTL in 51 Cr release assays. The CD4 ϩ -T-lymphocyte-mediated cytotoxicity identified in the present study was consistent with MHC-re- Mixed effectors were incubated with or without monoclonal antibodies to CD4 or CD8 with or without concanamycin A (CA) in the cytotoxicity assay. In all groups treated with concanamycin A, killing was blocked by at least 72%. The percent specific lysis of CD4 ϩ effectors was reduced by 74% when the perforin pathway was blocked (anti-CD8 ϩ plus concanamycin A group compared to anti-CD8 ϩ alone group). Effectors were 86% CD4 ϩ , 11% CD8 ϩ , and Ͻ1% ␥␦ T lymphocytes as determined by flow cytometry. The results are one of two similar experiments. Error bars indicate the SEM. (10, 33, 37, 51) ; however, the relative importance of CD4 ϩ and CD8 ϩ CTL and the biologic significance of CD4 ϩ CTL in toxoplasmosis are not known. Whether CTL exert protective effects by killing the intracellular parasites is a subject of debate, since one study indicated that lysis of T. gondii-infected cells did not lead to parasite death (50) . However, lysis of infected cells could facilitate phagocytosis of parasites and parasite antigens released from the parasitophorous vacuole by activated macrophages and result in increased presentation of parasite antigens in the context of MHC class II molecules (15, 29) . This would likely result in T-lymphocyte secretion of IFN-␥ (45), a cytokine that enhances CTL activity in T. gondii-specific, human CD4 ϩ CTL (51) and that has parasite antiproliferative effects (46, 49) .
Our findings are consistent with studies in which human T. gondii-specific CD4 ϩ CTL were expanded in vitro by using similar culture conditions (10, 33, 37, 51) and concur with depletion and enrichment experiments in which the human CD8 ϩ T lymphocyte subset also failed to kill infected targets (37) . The expansion of CTL in vitro by stimulating T lymphocytes with N. caninum tachyzoite-infected PBAC may not be representative of in vivo subset expansion, and the use of PBAC as stimulators may preferentially expand CD4 ϩ CTL in vitro. The PBAC used as stimulators adhered to polystyrene culture flasks, had the morphology of macrophages, and were likely primarily mononuclear phagocytes that expressed both MHC class I and class II molecules. In our stimulator cultures, the tachyzoites might actively invade PBAC and reside in parasitophorous vacuoles. In the case of active invasion, some intracellular parasite antigens from the parasitophorous vacuoles could be processed through the endogenous antigen-processing pathways for presentation in the context of MHC class I molecules and recognition by CD8 ϩ CTL. On the other hand, many tachyzoites and tachyzoite antigens in the cultures could also be phagocytosed and enter the exogenous phagolysosomal antigen-processing pathway for presentation in the context of MHC class II molecules and recognition by CD4 ϩ CTL. Antigen processing and presentation primarily through the exogenous pathway might preferentially expand CD4 ϩ CTL. The percentage of CD8 ϩ T lymphocytes from the peripheral blood of the infected cattle was commonly 20%, whereas after a 1-week stimulation, the CD8 ϩ -T-lymphocyte population generally dropped to 1 to 11% of the total effector population. Stimulation of effectors by parasite antigens primarily processed through the exogenous antigen-processing pathway and presented in the context of MHC class II molecules may be one explanation for selective expansion of CD4 ϩ CTL in this culture system.
In the present study, inhibition of the perforin/granzyme pathway abrogated killing by N. caninum-specific CD4 ϩ CTL. Other instances of killing by CD4 ϩ CTL through perforin/ granzyme pathways are found in intracellular infections of humans (4, 24, 52) and mice (48) . In a murine toxoplasmosis model, when the Fas/FasL pathway of T. gondii-specific CD8 ϩ T lymphocytes was inhibited, killing of infected cells by CTL and parasite proliferation within cells was not altered, whereas inhibition of the granule exocytosis pathway resulted in a significant reduction in the cytotoxic and parasite antiproliferative effects of CD8 ϩ T lymphocytes (34) . Granulysin, a protein released from intracellular compartments during granule exocytosis, has demonstrated antimicrobial activity (39) and may contribute to the antiproliferative effects of CTL in human toxoplasmosis. These observations lend support for a protective role mediated by CTL using granule exocytosis pathways in resistance to infections caused by apicomplexan protozoa. Recent studies suggest a link between the perforin/granzyme and Fas/FasL killing pathways. FasL has been localized to cytoplasmic granules that stored perforin and granzyme and may participate in granule-mediated cytotoxicity (25) . The killing pathways used by CTL may not be mutually exclusive, and the relative importance of Fas/FasL and perforin/granzyme-mediated killing by CTL in N. caninum infection remains to be elucidated.
Blocking with antibody to CD4 ϩ significantly reduced killing by the effector population in some experiments (Fig. 4) , suggesting that the unblocked CD8 ϩ effector subset did not contribute to killing. In other instances of blocking with antibody to CD4
ϩ , killing, presumably by the unblocked CD8 ϩ effector subset, remained (Fig. 2) . One explanation for this apparent discrepancy was incomplete blocking by the anti-CD4 ϩ antibody, since in later experiments with immunomagnetically purified CD4 ϩ T lymphocytes this subset had cytolytic activity (Fig. 3) , whereas purified CD8 ϩ T lymphocytes did not kill infected, autologous targets. Another possible explanation is that frequencies of CD4 ϩ and CD8 ϩ CTL varied over the time course of experimental infection. Cattle were reinfected with tachyzoites at monthly intervals to maintain persistent infection, but blood for assays was drawn irrespective of reinfection dates. It is possible that CD4 ϩ and CD8 ϩ CTL memory frequencies and ratios differed throughout the time course of reinfections and that CD8 ϩ CTL could have been present in antibody blocking experiments performed earlier in infection.
The presence of N. caninum-specific CTL that kill infected targets suggests that a parasite-specific immune response can be mediated by CTL in infected Holstein cattle, a natural, outbred host for this infection. CD4 ϩ CTL that kill through perforin-granzyme release may indicate an adaptive, preferential use of secretory pathways due to antiproliferative effects of granule contents such as granulysin. Induction of N. caninumspecific CTL in cattle immediately prior to gestation and in critical periods of suppressed natural immunity during gestation could limit maternal parasitemia either after acute or recrudescent infection. Priming the immune system of adult, naive cattle with N. caninum antigens restricted by specific Holstein MHC haplotypes and induction of sufficient numbers of memory CTL could result in decreased parasite numbers, decreased rate and severity of transplacental parasite transmission, and reductions in abortions due to N. caninum. Experiments that determine N. caninum CTL epitopes presented by specific bovine MHC molecules could also lead to identification of Holstein cattle with MHC haplotypes that are more resistant to N. caninum abortion and aid in the selection of sires used in artificial insemination breeding programs.
The studies presented here will facilitate (i) selection of immunogens that induce parasite-specific CTL in cattle, (ii) mapping of N. caninum epitopes that are presented by common Holstein MHC class II haplotypes, and (iii) testing whether induction of N. caninum specific CTL will limit transplacental N. caninum transmission in the outbred bovine host.
